
Is VUG a Good ETF to Buy?
For the last few years, earnings growth from the tech…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
04/25/2025 | Q1 | $2.2B | -- | -- | $38.20 | -- |
01/24/2025 | Q4 | $2.2B | $2.4B | $49.21 | $39.11 | $10.10 |
10/24/2024 | Q3 | $2.3B | $2.4B | $43.42 | $47.50 | -$4.08 |
07/25/2024 | Q2 | $2.3B | $2.4B | $47.54 | $45.00 | $2.54 |
04/25/2024 | Q1 | $2.4B | $2.4B | $49.26 | $44.15 | $5.11 |
01/26/2024 | Q4 | $2.4B | $2.3B | $34.33 | $49.34 | -$15.01 |
10/26/2023 | Q3 | -- | -- | $50.67 | $48.83 | $1.84 |
08/03/2023 | Q2 | -- | -- | $45.87 | $48.15 | -$2.28 |
05/10/2023 | Q1 | -- | -- | $653.64 | $12.51 | $641.13 |
01/26/2023 | Q4 | -- | -- | $16.70 | $22.98 | -$6.28 |
10/27/2022 | Q3 | -- | -- | $19.25 | $19.65 | -$0.40 |
07/28/2022 | Q2 | -- | -- | $14.86 | $17.02 | -$2.16 |
04/28/2022 | Q1 | -- | -- | $16.70 | $8.53 | $8.17 |
01/26/2022 | Q4 | -- | -- | $12.09 | $10.95 | $1.14 |
10/27/2021 | Q3 | -- | -- | $12.17 | $11.21 | $0.96 |
08/03/2021 | Q2 | -- | -- | $15.09 | $11.98 | $3.12 |
04/28/2021 | Q1 | -- | -- | $14.53 | $11.94 | $2.60 |
01/26/2021 | Q4 | -- | -- | $13.59 | -- | -- |
10/27/2020 | Q3 | -- | -- | $14.03 | -- | -- |
07/28/2020 | Q2 | -- | -- | $14.74 | -- | -- |
04/28/2020 | Q1 | -- | -- | $5.46 | -- | -- |
01/28/2020 | Q4 | -- | -- | $9.55 | -- | -- |
10/29/2019 | Q3 | -- | -- | $11.27 | -- | -- |
07/30/2019 | Q2 | -- | -- | $10.56 | -- | -- |
04/30/2019 | Q1 | -- | -- | $9.67 | -- | -- |
01/30/2019 | Q4 | -- | -- | $7.62 | -- | -- |
10/24/2018 | Q3 | -- | -- | $9.80 | -- | -- |
07/26/2018 | Q2 | -- | -- | $7.77 | -- | -- |
04/25/2018 | Q1 | -- | -- | $8.35 | -- | -- |
01/31/2018 | Q4 | -- | -- | $4.53 | -- | -- |
10/25/2017 | Q3 | -- | -- | $5.58 | -- | -- |
07/26/2017 | Q2 | -- | -- | $11.21 | -- | -- |
04/26/2017 | Q1 | -- | -- | $5.63 | -- | -- |
01/25/2017 | Q4 | -- | -- | $4.39 | -- | -- |
10/26/2016 | Q3 | -- | -- | $4.28 | -- | -- |
07/27/2016 | Q2 | -- | -- | $5.77 | -- | -- |
04/27/2016 | Q1 | -- | -- | $4.34 | -- | -- |
01/27/2016 | Q4 | -- | -- | $3.56 | -- | -- |
10/28/2015 | Q3 | -- | -- | $4.66 | -- | -- |
07/29/2015 | Q2 | -- | -- | $3.71 | -- | -- |
05/07/2015 | Q1 | -- | -- | $5.59 | $2.65 | $2.94 |
First Citizens BancShares reported $2.4B worth of top line sales in its most recent quarter.
First Citizens BancShares announced earnings per share of $49.21 which represents a beat of analyst forecast a $39.11 per share.
First Citizens BancShares reported -- that represents -- per share over the last quarter.
First Citizens BancShares's earnings are forecast to decrease from $189.41 per share to $187.88 per share next year representing a decrease of -10.98%.
First Citizens BancShares's next earnings date is April 25, 2025.
Signup to receive the latest stock alerts
For the last few years, earnings growth from the tech…
Intel Corporation (NASDAQ:INTC)’s recent innovations, Xeon 6 SoC and Xeon®…
For many years, Walmart (NYSE:WMT) has been the world’s largest…
Market Cap: $3.3T
P/E Ratio: 36x
Market Cap: $2.8T
P/E Ratio: 32x
Market Cap: $2.7T
P/E Ratio: 37x
Guardant Health [GH] is up 1.1% over the past day.
Teradyne [TER] is down 0.36% over the past day.
Limbach Holdings [LMB] is down 4.39% over the past day.